Shinichiro Seki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shinichiro Seki has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Yoshiharu Ohno
Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan
8 shared publications - Hisanobu Koyama
Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
7 shared publications - Takeshi Yoshikawa
Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan
6 shared publications - Kazuro Sugimura
Division of Radiology, Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan
4 shared publications - Yuji Kishida
Division of Radiology, Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan
4 shared publications - Daisuke Takenaka
Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan
2 shared publications
Latest Publications
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , 432-443
Differentiation of Benign from Malignant Pulmonary Nodules by Using a Convolutional Neural Network to Determine Volume Change at Chest CT
A convolutional neural network combined with computer-aided detection of pulmonary nodule volume at CT showed that nodule volume change per day was a better predictor of malignancy than was nodule ... Background Deep learning may help to improve computer-aided detection of volume (CADv) measurement of pulmonary nodules at chest CT. Purpose To determine the efficacy of a deep learning method for ...
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , 432-443
Differentiation of Benign from Malignant Pulmonary Nodules by Using a Convolutional Neural Network to Determine Volume Change at Chest CT
A convolutional neural network combined with computer-aided detection of pulmonary nodule volume at CT showed that nodule volume change per day was a better predictor of malignancy than was nodule ... Background Deep learning may help to improve computer-aided detection of volume (CADv) measurement of pulmonary nodules at chest CT. Purpose To determine the efficacy of a deep learning method for ...
- 1 February 2019
- Published by Elsevier in European Journal of Radiology
- Vol. 111, 93-103
Radiation dose reduction techniques for chest CT: Principles and clinical results
- 1 February 2019
- Published by Elsevier in European Journal of Radiology
- Vol. 111, 93-103
Radiation dose reduction techniques for chest CT: Principles and clinical results
- 1 November 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 209 (5) , W253-W262
Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non–Small Cell Lung Cancer
OBJECTIVE. The objective of our study was to directly compare the capability of dynamic first-pass contrast-enhanced (CE) perfusion area-detector CT (ADCT) and FDG PET/CT for differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with non–small cell lung carcinoma (NSCLC). SUBJECTS AND METHODS. Seventy-seven consecutive patients, 45 men (mean age ± SD, 70.4 ± 5.9 years) and 32 women (71.2 ± 7.7 years), underwent dynamic first-pass CE–perfusion ADCT at two or three different positions for covering the entire thorax, FDG PET/CT, surgical treatment, and pathologic examination. From all ADCT data for each of the subjects, a whole-chest perfusion map was computationally generated using the dual- and single-input maximum slope and Patlak plot methods. For quantitative N stage assessment, perfusion parameters and the maximum standardized uptake value (SUVmax) for each lymph node were determined by measuring the relevant ROI. ROC curve analyses were performed for comparing the diagnostic capability of each of the methods on a per-node basis. N stages evaluated by each of the indexes were then statistically compared with the final pathologic diagnosis by means of chi-square and kappa statistics. RESULTS. The area under the ROC curve (Az) values of systemic arterial perfusion (Az = 0.89), permeability surface (Az = 0.78), and SUVmax (Az = 0.85) were significantly larger than the Az values of total perfusion (Az = 0.70, p < 0.05) and distribution volume (Az = 0.55, p < 0.05). For each of the threshold values, agreement for systemic arterial perfusion calculated using the dual-input maximum slope model was substantial (κ = 0.70, p < 0.0001), and agreement for SUVmax was moderate (κ = 0.60, p < 0.0001). CONCLUSION. Dynamic first-pass CE–perfusion ADCT is as useful as FDG PET/CT for the differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with NSCLC.
- 1 November 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 209 (5) , W253-W262
Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non–Small Cell Lung Cancer
OBJECTIVE. The objective of our study was to directly compare the capability of dynamic first-pass contrast-enhanced (CE) perfusion area-detector CT (ADCT) and FDG PET/CT for differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with non–small cell lung carcinoma (NSCLC). SUBJECTS AND METHODS. Seventy-seven consecutive patients, 45 men (mean age ± SD, 70.4 ± 5.9 years) and 32 women (71.2 ± 7.7 years), underwent dynamic first-pass CE–perfusion ADCT at two or three different positions for covering the entire thorax, FDG PET/CT, surgical treatment, and pathologic examination. From all ADCT data for each of the subjects, a whole-chest perfusion map was computationally generated using the dual- and single-input maximum slope and Patlak plot methods. For quantitative N stage assessment, perfusion parameters and the maximum standardized uptake value (SUVmax) for each lymph node were determined by measuring the relevant ROI. ROC curve analyses were performed for comparing the diagnostic capability of each of the methods on a per-node basis. N stages evaluated by each of the indexes were then statistically compared with the final pathologic diagnosis by means of chi-square and kappa statistics. RESULTS. The area under the ROC curve (Az) values of systemic arterial perfusion (Az = 0.89), permeability surface (Az = 0.78), and SUVmax (Az = 0.85) were significantly larger than the Az values of total perfusion (Az = 0.70, p < 0.05) and distribution volume (Az = 0.55, p < 0.05). For each of the threshold values, agreement for systemic arterial perfusion calculated using the dual-input maximum slope model was substantial (κ = 0.70, p < 0.0001), and agreement for SUVmax was moderate (κ = 0.60, p < 0.0001). CONCLUSION. Dynamic first-pass CE–perfusion ADCT is as useful as FDG PET/CT for the differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with NSCLC.
- 17 April 2017
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 46 (6) , 1707-1717
Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non‐small cell lung cancer
Purpose To compare the diagnostic performance of positron emission tomography with [18F] fluoro‐2‐deoxy‐glucose (FDG‐PET) coregistered with magnetic resonance imaging (FDG‐PET/MRI), MRI with and without diffusion‐weighted imaging (DWI), FDG‐PET fused with computed tomography (FDG‐PET/CT) with brain contrast‐enhanced (CE‐) MRI, and routine radiological examination for assessment of postoperative recurrence in nonsmall‐cell lung cancer (NSCLC) patients. Materials and Methods 96 consecutive postoperative NSCLC patients (52 men, 44 women; mean age 72 years) prospectively underwent whole‐body 3T MRI with and without DWI; PET/CTs and routine radiological examinations consisted of CE‐brain MRI, whole‐body CE‐CT, and bone scintigraphy. The patients were divided into a recurrence (n = 17) and a nonrecurrence (n = 79) group based on pathological and follow‐up examinations. All coregistered PET/MRIs were generated by proprietary software. The probability of recurrence was visually assessed on a per‐patient basis. Receiver operating characteristic analyses were used to compare the diagnostic performance of all methods. Finally, diagnostic capabilities were compared by means of McNemar's test. Results Areas under the curves (Azs) were significantly larger for PET/MRI and whole‐body MRI with DWI (Az = 0.99) than for PET/CT (Az = 0.92, P < 0.05) and conventional radiological examination (Az = 0.91, P < 0.05). Specificity and accuracy of PET/MRI and MRI with and without DWI were significantly higher than those of PET/CT (P < 0.05) and routine radiological examination (P < 0.05). Conclusion Whole‐body FDG‐PET/MRI and MRI with DWI were found to be more specific and accurate than FDG‐PET/CT and routine radiological examinations for assessment of recurrence in NSCLC patients, although MRI with and without DWI demonstrated slightly lower sensitivity than PET/CT. Level of Evidence: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1707–1717.
- 17 April 2017
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 46 (6) , 1707-1717
Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non‐small cell lung cancer
Purpose To compare the diagnostic performance of positron emission tomography with [18F] fluoro‐2‐deoxy‐glucose (FDG‐PET) coregistered with magnetic resonance imaging (FDG‐PET/MRI), MRI with and without diffusion‐weighted imaging (DWI), FDG‐PET fused with computed tomography (FDG‐PET/CT) with brain contrast‐enhanced (CE‐) MRI, and routine radiological examination for assessment of postoperative recurrence in nonsmall‐cell lung cancer (NSCLC) patients. Materials and Methods 96 consecutive postoperative NSCLC patients (52 men, 44 women; mean age 72 years) prospectively underwent whole‐body 3T MRI with and without DWI; PET/CTs and routine radiological examinations consisted of CE‐brain MRI, whole‐body CE‐CT, and bone scintigraphy. The patients were divided into a recurrence (n = 17) and a nonrecurrence (n = 79) group based on pathological and follow‐up examinations. All coregistered PET/MRIs were generated by proprietary software. The probability of recurrence was visually assessed on a per‐patient basis. Receiver operating characteristic analyses were used to compare the diagnostic performance of all methods. Finally, diagnostic capabilities were compared by means of McNemar's test. Results Areas under the curves (Azs) were significantly larger for PET/MRI and whole‐body MRI with DWI (Az = 0.99) than for PET/CT (Az = 0.92, P < 0.05) and conventional radiological examination (Az = 0.91, P < 0.05). Specificity and accuracy of PET/MRI and MRI with and without DWI were significantly higher than those of PET/CT (P < 0.05) and routine radiological examination (P < 0.05). Conclusion Whole‐body FDG‐PET/MRI and MRI with DWI were found to be more specific and accurate than FDG‐PET/CT and routine radiological examinations for assessment of recurrence in NSCLC patients, although MRI with and without DWI demonstrated slightly lower sensitivity than PET/CT. Level of Evidence: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1707–1717.
- 1 January 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (1) , 164-175
Hybrid Type iterative reconstruction method vs. filter back projection method: Capability for radiation dose reduction and perfusion assessment on dynamic first-pass contrast-enhanced perfusion chest area-detector CT
- 1 January 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (1) , 164-175
Hybrid Type iterative reconstruction method vs. filter back projection method: Capability for radiation dose reduction and perfusion assessment on dynamic first-pass contrast-enhanced perfusion chest area-detector CT
- 19 October 2015
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 17 (12) , 69
State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD)
Involvement of the respiratory system is common in connective tissue diseases (CTDs), and the resultant lung injury can affect every part of the lung: the pleura, alveoli, interstitium, vasculature, lymphatic tissue, and large and/or small airways. Most of the parenchymal manifestations of CTD are similar to those found in interstitial lung diseases (ILDs), especially idiopathic interstitial pneumonias, and can be classified using the same system. Although there is some overlap, each CTD is associated with a characteristic pattern of pulmonary involvement. For this reason, thin-section CT as well as pulmonary function tests and serum markers are utilized for diagnosis, disease severity assessment, and therapeutic efficacy evaluation of ILD associated with CTD. In addition, newly developed pulmonary magnetic resonance imaging (MRI) procedures have been recommended as useful alternative imaging options for patients with CTD. This review article will (1) address radiological findings for chest radiography and conventional or thin-section CT currently used for six major types of CTD, rheumatoid arthritis, scleroderma (progressive systemic sclerosis), polymyositis/dermatomyositis, systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease; (2) briefly deal with radiation dose reduction for thin-section CT examination; and (3) discuss clinically applicable or state-of-the-art MR imaging for CTD patients.
- 19 October 2015
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 17 (12) , 69
State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD)
Involvement of the respiratory system is common in connective tissue diseases (CTDs), and the resultant lung injury can affect every part of the lung: the pleura, alveoli, interstitium, vasculature, lymphatic tissue, and large and/or small airways. Most of the parenchymal manifestations of CTD are similar to those found in interstitial lung diseases (ILDs), especially idiopathic interstitial pneumonias, and can be classified using the same system. Although there is some overlap, each CTD is associated with a characteristic pattern of pulmonary involvement. For this reason, thin-section CT as well as pulmonary function tests and serum markers are utilized for diagnosis, disease severity assessment, and therapeutic efficacy evaluation of ILD associated with CTD. In addition, newly developed pulmonary magnetic resonance imaging (MRI) procedures have been recommended as useful alternative imaging options for patients with CTD. This review article will (1) address radiological findings for chest radiography and conventional or thin-section CT currently used for six major types of CTD, rheumatoid arthritis, scleroderma (progressive systemic sclerosis), polymyositis/dermatomyositis, systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease; (2) briefly deal with radiation dose reduction for thin-section CT examination; and (3) discuss clinically applicable or state-of-the-art MR imaging for CTD patients.
- 13 March 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (5) , 835-842
Diffusion-weighted MR imaging vs. multi-detector row CT: Direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors
- 13 March 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (5) , 835-842
Diffusion-weighted MR imaging vs. multi-detector row CT: Direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors
- 9 September 2013
- Published by Elsevier in European Journal of Radiology
- Vol. 82 (11) , 2018-2027
Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients
- 9 September 2013
- Published by Elsevier in European Journal of Radiology
- Vol. 82 (11) , 2018-2027
Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients